Term
| glucose targets in geriatrics: fasting |
|
Definition
| shoot for higher end (12-130); instead of lower end (80) |
|
|
Term
| may need pressure a little higher |
|
Definition
| for appropriate organ perfusion |
|
|
Term
| dehydration (real problem in elderly); meds; medical conditions |
|
Definition
|
|
Term
| when glucose is too low: <70 and not causing hypoglycemia symptoms |
|
Definition
| may damage heart/cause cardiovascular damage; body responds with inflammation |
|
|
Term
| most long acting sulfonylurea; more likely to cause hypoglycemia and accumulate in geriatrics |
|
Definition
|
|
Term
| sulfonylureas that are more preferred in geriatric patients |
|
Definition
|
|
Term
| oral diabetes meds that do not increase insulin release = lower incidence of hypoglycemia |
|
Definition
| metformin, glitazones, alpha glucosidase inhibitors |
|
|
Term
|
Definition
| Actos and Avandia; Cardiac issues especially with Avandia |
|
|
Term
| alpha glucosidase inhibitors |
|
Definition
| delay breakdown of carbs, very helpful for post prandial hyperglcemia |
|
|
Term
|
Definition
| diarrhea = main limiting factor; must titrate SLOWLY |
|
|
Term
| what are the lower limits for blood pressure in geriatrics? |
|
Definition
| do not have; VADT-BP trials used < 105/70 as cutoff in CAD patients |
|
|
Term
| over time induced vessel relaxation; focuses on lowering systolic and minimally lowers diastolic |
|
Definition
| Diuretics - hydrochlorothiazide (NOT furosemide) |
|
|
Term
| can be used in isolated systolic hypertension: watch heart rate |
|
Definition
| verapamil ad diltiazem (can also use DHPs) |
|
|
Term
| can help with cardiac remodeling in systolic heart failure |
|
Definition
|
|
Term
|
Definition
| changes occur in the heart over time causing remodeling due to insufficiency |
|
|
Term
|
Definition
| ACEIs, ARBs, BBs, Spironolactone can all be helpful for prevention |
|
|
Term
| can worsen systolic heart failure if increased too quickly |
|
Definition
|
|
Term
| beta blockers in cardiac remodeling |
|
Definition
| helpful long term but increased/too high dosage short term can be damaging to the heart |
|
|
Term
|
Definition
| ACEIs/ARBs and spironolactone |
|
|
Term
| usually needs 2-3 years to see benefit |
|
Definition
|
|
Term
| > 80 years old; statin use controversial |
|
Definition
| possibly increased non-CV mortalilty; likely still beneficial for CV mortality |
|
|
Term
| statins in elderly: chasing numbers or treating CV disease? |
|
Definition
| some fats may be necessary; some less dense LDL may have protective roles; may cause worsening dementia long term |
|
|
Term
|
Definition
| GI upset, dental issues, weird fractures, Afib |
|
|
Term
|
Definition
| txt benefit over 5 years? 3 years for benefit for fracture reduction |
|
|
